BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38386050)

  • 1. Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
    Zhu JQ; Zhu Y; Qi M; Zeng Y; Liu ZJ; Ding C; Zhang T; Li XL; Han DD; He Q
    Cancer Immunol Immunother; 2024 Feb; 73(3):58. PubMed ID: 38386050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing.
    Cheng M; Liang G; Yin Z; Lin X; Sun Q; Liu Y
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5497-5512. PubMed ID: 36469154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.
    Lunsford KE; Javle M; Heyne K; Shroff RT; Abdel-Wahab R; Gupta N; Mobley CM; Saharia A; Victor DW; Nguyen DT; Graviss EA; Kaseb AO; McFadden RS; Aloia TA; Conrad C; Li XC; Monsour HP; Gaber AO; Vauthey JN; Ghobrial RM;
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):337-348. PubMed ID: 29548617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrahepatic cholangiocarcinoma--a rare indication for liver transplantation. Case report and review of the literature.
    Hrehoreţ D; Alexandrescu S; Grigorie R; Herlea V; Anghel R; Popescu I
    Chirurgia (Bucur); 2012; 107(2):237-42. PubMed ID: 22712355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for intrahepatic cholangiocarcinoma.
    Hashimoto K; Miller CM
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):138-43. PubMed ID: 25214036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.
    Li H; Qu L; Yang Y; Zhang H; Li X; Zhang X
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1592-1609.e9. PubMed ID: 35219893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsatisfactory Long-term Results of Liver Transplant in Patients With Intrahepatic Cholangiocarcinoma.
    Krasnodębski M; Grąt M; Jastrzębski M; Szczęśniak M; Morawski M; Zając K; Patkowski W; Zieniewicz K
    Transplant Proc; 2020 Oct; 52(8):2463-2467. PubMed ID: 32327261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
    Zeng TM; Pan YF; Yuan ZG; Chen DS; Song YJ; Gao Y
    Front Immunol; 2022; 13():943066. PubMed ID: 36159865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for intrahepatic cholangiocarcinoma after liver transplantation by size of tumor.
    Zeng L; He C; Li X
    Surgery; 2023 Oct; 174(4):1094. PubMed ID: 36792459
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
    Huang YH; Zhang CZ; Huang QS; Yeong J; Wang F; Yang X; He YF; Zhang XL; Zhang H; Chen SL; Zheng YL; Deng R; Lin CS; Yang MM; Li Y; Jiang C; Kin-Wah Lee T; Ma S; Zeng MS; Yun JP
    J Hepatol; 2021 Apr; 74(4):838-849. PubMed ID: 33212090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities.
    Lin J; Dai Y; Sang C; Song G; Xiang B; Zhang M; Dong L; Xia X; Ma J; Shen X; Ji S; Zhang S; Wang M; Fang H; Zhang X; Wang X; Zhang B; Zhou J; Fan J; Zhou H; Gao D; Gao Q
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
    J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.
    Özdemir BH
    Exp Clin Transplant; 2023 Apr; 21(4):291-298. PubMed ID: 35297332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of intrahepatic cholangiocarcinoma].
    Lamesch P; Weimann A; Hauss J; Pichlmayr R
    Chirurgie; 1997; 122(2):88-91. PubMed ID: 9238798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Very early" intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?
    Sapisochin G; Rodríguez de Lope C; Gastaca M; Ortiz de Urbina J; Suarez MA; Santoyo J; Castroagudín JF; Varo E; López-Andujar R; Palacios F; Sanchez Antolín G; Perez B; Guiberteau A; Blanco G; González-Diéguez ML; Rodriguez M; Varona MA; Barrera MA; Fundora Y; Ferron JA; Ramos E; Fabregat J; Ciria R; Rufian S; Otero A; Vazquez MA; Pons JA; Parrilla P; Zozaya G; Herrero JI; Charco R; Bruix J
    Am J Transplant; 2014 Mar; 14(3):660-7. PubMed ID: 24410861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma.
    Rauchfuß F; Ali-Deeb A; Rohland O; Dondorf F; Ardelt M; Settmacher U
    Curr Oncol; 2022 Mar; 29(3):1932-1938. PubMed ID: 35323357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplant for Intrahepatic Cholangiocarcinoma.
    Eletta OA; Panayotova GG; Lunsford KE
    Surg Clin North Am; 2024 Feb; 104(1):215-225. PubMed ID: 37953037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation.
    Maganty K; Levi D; Moon J; Bejarano PA; Arosemena L; Tzakis A; Martin P
    Dig Dis Sci; 2010 Dec; 55(12):3597-601. PubMed ID: 20848202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.